INNATE PHARMA SA (IPHYF:OTCMKTS)
$0 None (None%)
Analysed INNATE PHARMA SA (IPHYF:OTCMKTS) News Sources
Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update
10-09-2026
yahoo.com
Innate and Sobi Announce Partnership Is Now Effective Following Completion of Closing Conditions
16-09-2026
yahoo.com
Sobi and Innate announce partnership is now effective following completion of closing conditions
17-09-2026
yahoo.com
Innate Pharma Reports First Half 2026 Business Update and Financial Results
17-09-2026
yahoo.com
Innate Pharma Q2 Earnings Call Highlights
17-09-2026
marketbeat.com
Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript
18-09-2026
fool.com
Innate Pharma (IPHA) Closes Sobi Deal. Can the New Funding Keep Drug Trials on Track?
23-09-2026
yahoo.com
Innate Pharma (IPHA) Upgraded to Buy: Here's What You Should Know
23-09-2026
yahoo.com
Down 25% in 4 Weeks, Here's Why You Should You Buy the Dip in Innate Pharma (IPHA)
05-10-2026
yahoo.com
Down 22% in 4 Weeks, Here's Why Innate Pharma (IPHA) Looks Ripe for a Turnaround
08-10-2026
yahoo.com
What is the current price of INNATE PHARMA SA (IPHYF:OTCMKTS)?
The current price of INNATE PHARMA SA (IPHYF:OTCMKTS) is $0.
INNATE PHARMA SA (IPHYF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of INNATE PHARMA SA (IPHYF:OTCMKTS) since the previous trading day is $None.
INNATE PHARMA SA (IPHYF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of INNATE PHARMA SA (IPHYF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for INNATE PHARMA SA (IPHYF:OTCMKTS)?
The most recent average sentiment score for INNATE PHARMA SA (IPHYF:OTCMKTS) is 52 out of 100.
What is the most recent average sentiment for INNATE PHARMA SA (IPHYF:OTCMKTS)?
The most recent sentiment for INNATE PHARMA SA (IPHYF:OTCMKTS) is .
SEC-8K** Filing Available For INNATE PHARMA SA (IPHYF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.